Segall Bryant & Hamill LLC Buys 90,443 Shares of RadNet, Inc. (NASDAQ:RDNT)

Segall Bryant & Hamill LLC boosted its holdings in RadNet, Inc. (NASDAQ:RDNT - Free Report) by 75.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 209,582 shares of the medical research company's stock after buying an additional 90,443 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.28% of RadNet worth $14,543,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in RDNT. Allspring Global Investments Holdings LLC increased its stake in RadNet by 103.8% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,011,974 shares of the medical research company's stock worth $59,626,000 after acquiring an additional 515,342 shares during the last quarter. 8 Knots Management LLC purchased a new stake in RadNet in the first quarter valued at approximately $20,273,000. Vanguard Group Inc. lifted its position in RadNet by 8.1% during the first quarter. Vanguard Group Inc. now owns 4,600,539 shares of the medical research company's stock valued at $223,862,000 after purchasing an additional 345,822 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in RadNet by 130.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 402,205 shares of the medical research company's stock worth $27,909,000 after buying an additional 227,713 shares in the last quarter. Finally, Whittier Trust Co. purchased a new position in RadNet in the 2nd quarter worth approximately $11,069,000. Institutional investors own 77.90% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Jefferies Financial Group boosted their target price on RadNet from $75.00 to $80.00 and gave the stock a "buy" rating in a research report on Thursday, September 19th. Truist Financial increased their target price on shares of RadNet from $70.00 to $80.00 and gave the company a "buy" rating in a report on Monday, September 23rd. Barclays upgraded shares of RadNet from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $57.00 to $79.00 in a research report on Friday, September 6th. Finally, Sidoti raised RadNet to a "strong-buy" rating in a research note on Friday, October 4th. One research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $74.75.

RadNet Trading Up 2.9 %

Shares of RDNT opened at $82.16 on Thursday. The firm has a fifty day simple moving average of $70.04 and a two-hundred day simple moving average of $63.57. RadNet, Inc. has a twelve month low of $31.55 and a twelve month high of $93.65. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.16 and a quick ratio of 2.16.

RadNet Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.